Safety and efficacy of glycopyrrolate oral solution for management of pathologic drooling in pediatric patients with cerebral palsy and other neurologic conditions

BACKGROUND: The purpose of this study was to assess the safety and efficacy of oral glycopyrrolate solution 1 mg/5 mL for 24 weeks in pediatric patients with chronic moderate-to- severe drooling associated with cerebral palsy and other neurologic conditions. METHODS: In this multicenter, open-label,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeller, Robert S, Davidson, Jennifer, Lee, Hak-Myung, Cavanaugh, Paul F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269348/
https://www.ncbi.nlm.nih.gov/pubmed/22298951
http://dx.doi.org/10.2147/TCRM.S27362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269348/
https://www.ncbi.nlm.nih.gov/pubmed/22298951
http://dx.doi.org/10.2147/TCRM.S27362

Ejemplares similares